As of Mar 29
| -0.08 / -0.18%|
The 27 analysts offering 12-month price forecasts for Sanofi have a median target of 45.39, with a high estimate of 53.89 and a low estimate of 37.09. The median estimate represents a +0.27% increase from the last price of 45.27.
The current consensus among 30 polled investment analysts is to Hold stock in Sanofi. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.